Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Coherus Oncology Inc (CHRS)

143 + Investors. Track Smart Money conviction in CHRS. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -11
Streak
1Q ▼
Buyers last Q
54%

Smart Money Signals — CHRS

Based on 145 hedge funds · latest filing: 2026 Q2 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their CHRS positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 90% of 3.0Y peak

90% of all-time peak
145 funds currently hold this stock — 90% of the 3.0-year high of 161 funds (reached 2023 Q3). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
🚀

Fast accumulation — +32% more funds vs a year ago

fund count last 6Q
+35 new funds entered over the past year (+32% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 54% buying

77 buying65 selling
Last quarter: 77 funds bought or added vs 65 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-30 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 22 → 28 → 43 → 13. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

54% of holders stayed for 2+ years

54% conviction (2yr+) 23% medium 23% new
78 out of 145 hedge funds have held CHRS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +6%, value -10%

Value
-10%
Shares
+5%
Last quarter: funds added +6% more shares while total portfolio value only changed -10%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

13 → 22 → 28 → 43 → 13 new funds/Q
New funds entering each quarter: 22 → 28 → 43 → 13. A growing number of institutions are discovering CHRS each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 58% veterans vs 26% newcomers

58% veterans 15% 1-2yr 26% new
Entry-cohort mix of 149 holders: 87 (58%) are 2+ year veterans, 23 entered 1–2 years ago, and 39 (26%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 47% AUM from top-100 funds

47% from top-100 AUM funds
40 of 145 holders are among the 100 largest funds by AUM, controlling 47% of total institutional value in CHRS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.7
out of 10
Low Exit Risk
Exit risk score 3.7/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CHRS

In 2026 Q2, 77 hedge funds were net buyers of CHRS (13 opened a new position, 64 added to an existing one), while 65 reduced or exited (41 trimmed, 24 sold completely) — a 54% buyer ratio, indicating a slight buying edge. 47% of total institutional value in CHRS is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -11 funds (more exits than new entries). Total institutional holders: 145.

Hedge Fund Ownership: CHRS

How many hedge funds hold CHRS — quarterly history vs. share price
Quarterly hedge fund ownership of CHRS vs. share price

Market Analysis: CHRS

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CHRS

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

8 top-rated funds 2 high-conviction
Consensus
4.1
/ 10
breadth
×
Elite
1.7
/ 10
conviction
Hedge Fund Positioning: CHRS
143 + Investors

Track Smart Money conviction in CHRS. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 143 156 -8.33%
13F Shares 63M 60M 5.86%
Total Value $85M $96M -11.9%
New Positions 12 43 -31
Increased Positions 62 47 +15
Closed Positions 25 14 +11
Reduced Positions 40 36 +4
Total Calls 2 2 -
Total Puts 2 2 -
PUT/CALL Ratio 1.0 1.0 Neutral

Statistics: CHRS

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

143 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CHRS. Verified SEC 13F-HR filings.

QUARTER:
Top 25 CHRS holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Timothy G. Youngquist 2020 Irrevocable Trust 6.13% 5,895,349 $8.4M
2 CM Management, LLC 1.87% 2,100,000 $2.9M
3 Samsara BioCapital, LLC 0.39% 3,428,571 $4.8M
4 Pvg Asset Management Corp 0.11% 133,235 $187K
5 Kohlberg Kravis Roberts & Co. L.P. 0.07% 3,036,076 $4.2M
6 Spark Investment Management LLC 0.05% 17,800 $25K
7 Tyche Wealth Partners LLC 0.04% 201,202 $282K
8 Canton Hathaway, LLC 0.02% 58,230 $82K
9 Kmt Wealth Management, LLC 0.01% 12,396 $17K
10 Kingsbury Capital Investment Advisors LLC 0.01% 12,396 $17K
11 Providence Wealth Advisors, LLC 0.01% 15,000 $22K
12 Carr Financial Group Corp 0.01% 35,195 $49K
13 Headlands Technologies LLC 0.01% 69,191 $97K
14 Bridgeway Capital Management, LLC 0.01% 391,000 $547K
15 Shay Capital LLC 0.01% 105,326 $147K
16 Medallion Wealth Advisors, LLC 0.01% 15,000 $21K
17 Hudson Bay Capital Management LP 0.01% 1,693,000 $2.4M
18 Alyeska Investment Group, L.P. 0.01% 1,733,234 $2.4M
19 Endowment Wealth Management, Inc. 0.01% 11,521 $16K
20 Panagora Asset Management Inc 0.00% 1,137,325 $1.6M
21 International Assets Investment Management, LLC 0.00% 42,958 $62K
22 Curated Wealth Partners LLC 0.00% 20,000 $22K
23 SteelPeak Wealth, LLC 0.00% 69,000 $97K
24 Jefferies Financial Group Inc. 0.00% 252,000 $353K
25 Bronte Capital Management Pty Ltd. 0.00% 15,262 $21K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Coherus Oncology Inc (CHRS)

What does the Smart Money Trend signal show for CHRS?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their CHRS positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for CHRS?

Slight buying edge — 54% buying: Last quarter: 77 funds bought or added vs 65 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for CHRS holders?

Elite ownership — 47% AUM from top-100 funds: 40 of 145 holders are among the 100 largest funds by AUM, controlling 47% of total institutional value in CHRS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held CHRS?

54% of holders stayed for 2+ years: 78 out of 145 hedge funds have held CHRS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →